Asset
OXYCODEGOL
Nektar Therapeutics Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01619839 | phase2 | completed | 2012-06-01 | 2013-08-01 | Nektar Therapeutics | A Phase 2 Study To Assess The Efficacy, Tolerability, And Safety OF NKTR-181 In Subjects With Chronic OA Knee Pain |
| NCT03802227 | phase1 | terminated | 2018-10-22 | 2019-12-17 | Nektar Therapeutics | A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users. |
FDA applications (0)
This company has no applications containing this asset.